Law Offices of Howard G. Smith Announces Class Action Lawsuit Against
BENSALEM, Pa. -- September 21, 2013
Law Offices of Howard G. Smith announces that a class action lawsuit has been
filed in the United States District Court for the Southern District of
California on behalf of a class (the “Class”) comprising all purchasers of the
securities of NuVasive, Inc. (“NuVasive” or the “Company”) (NASDAQ:NUVA)
between October 22, 2008 and July 30, 2013, inclusive (the “Class Period”).
NuVasive is a medical device company engaged in the design, development and
marketing of minimally disruptive surgical products and procedurally
integrated solutions for the spine. The Complaint alleges that defendants
issued false and/or misleading statements and failed to disclose material
adverse facts about NuVasive’s business, operations and prospects.
Specifically: (1) the Company improperly submitted false claims to Medicare
and Medicaid in violation of federal and state laws and regulations; and (2)
as a result of the foregoing, the Company’s statements were materially false
and misleading at all relevant times.
On July 30, 2013, the Company disclosed that it had received a federal
administrative subpoena from the Office of the Inspector General of the U.S.
Department of Health and Human Services in connection with an investigation
into “possible false or otherwise improper claims submitted to Medicare and
Medicaid.” As a result of this news, NuVasive securities declined $3.28 per
share, or over 12%, to close at $22.84 per share on July 31, 2013.
If you are a member of the Class described above you may move the Court no
later than October 28, 2013 to serve as lead plaintiff; however, you must meet
certain legal requirements.
No class has yet been certified in this action. Until a class is certified,
you are not represented by counsel unless you retain one. If you purchased
NuVasive securities during the Class Period you have certain rights, and have
until October 28, 2013 to move for lead plaintiff status. To be a member of
the Class you need not take any action at this time or you may retain counsel
of your choice. If you purchased NuVasive securities prior to the Class Period
and have any questions concerning this Notice or your rights or interests with
respect to these matters, please contact Howard G. Smith, Esquire, of Law
Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem,
Pennsylvania 19020 by telephone at (215) 638-4847, Toll Free at (888)
638-4847, or by email to email@example.com, or visit our website
Law Offices of Howard G. Smith
Howard G. Smith, Esquire
Press spacebar to pause and continue. Press esc to stop.